Brief: Reg-Arix Bioscience Appoints Joe Anderson As CEO
19/02/2019 07:23
Feb 19 (Reuters) - Arix Bioscience Plc ARIX.L :
* MANAGEMENT AND BOARD CHANGES
* CHIEF INVESTMENT OFFICER, JOE ANDERSON, HAS BEEN
REAPPOINTED AS
CHIEF EXECUTIVE OFFICER AND WILL RE-JOIN ARIX BOARD
Source text for Eikon: ID:nPRrJAA75a
Further company coverage: ARIX.L
((Reuters Messaging: Reuters.Briefs@thomsonreuters.com;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co